These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31083857)

  • 1. The relationship between serum levels of surfactant protein D in COPD exacerbation severity and mortality.
    Günaydın FE; Günlüoğlu G; Kalkan N; Aktepe EN; Demirkol B; Altın S
    Turk J Med Sci; 2019 Jun; 49(3):888-893. PubMed ID: 31083857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
    Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
    Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
    Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
    Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum surfactant protein D: biomarker of chronic obstructive pulmonary disease.
    Ju CR; Liu W; Chen RC
    Dis Markers; 2012; 32(5):281-7. PubMed ID: 22674408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.
    Labonté LE; Bourbeau J; Daskalopoulou SS; Zhang M; Coulombe P; Garland K; Baglole CJ
    PLoS One; 2016; 11(2):e0149974. PubMed ID: 26914709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
    Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of serum and induced sputum surfactant protein-D in chronic obstructive pulmonary disease.
    Ozyurek BA; Ulasli SS; Bozbas SS; Bayraktar N; Akcay S
    Multidiscip Respir Med; 2013 Jun; 8(1):36. PubMed ID: 23725346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary disease.
    Zien Alaabden A; Mohammad Y; Fahoum S
    Qatar Med J; 2015; 2015(2):18. PubMed ID: 26942111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
    Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
    Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucosylated surfactant protein-D is a biomarker candidate for the development of chronic obstructive pulmonary disease.
    Ito E; Oka R; Ishii T; Korekane H; Kurimoto A; Kizuka Y; Kitazume S; Ariki S; Takahashi M; Kuroki Y; Kida K; Taniguchi N
    J Proteomics; 2015 Sep; 127(Pt B):386-94. PubMed ID: 26206179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
    Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
    Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
    Fakih D; Akiki Z; Junker K; Medlej-Hashim M; Waked M; Salameh P; Holmskov U; Bouharoun-Tayoun H; Chamat S; Sorensen GL; Jounblat R
    Respirology; 2018 Mar; 23(3):298-305. PubMed ID: 28960651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
    Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
    Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
    Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease.
    El-Deek SE; Makhlouf HA; Saleem TH; Mandour MA; Mohamed NA
    Med Princ Pract; 2013; 22(5):469-74. PubMed ID: 23860258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein D as biomarkers for COPD.
    Duvoix A; Miranda E; Perez J; Sorensen GL; Holmskov U; Trapnell BC; Madsen J; Clark HW; Edwards LD; Miller BE; Tal-Singer RM; Lomas DA
    COPD; 2011 Apr; 8(2):79-95. PubMed ID: 21495836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.